ENG and choriocarcinoma: To investigate the potential role of CD105 in drug-resistant choriocarcinoma, we determined the expression of CD105 by western blotting, qRT-PCT and IF in JEG-3, JEG-3/FR and JEG-3/MR cells (Fig. 1).